Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:GKOS NASDAQ:IRTC NYSE:STVN NYSE:WRBY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGKOSGlaukos$80.72-2.5%$93.06$77.10▼$163.71$4.75B0.77635,607 shs1.21 million shsIRTCiRhythm Technologies$176.16-2.0%$157.12$55.92▼$187.57$5.78B1.1376,581 shs393,344 shsSTVNStevanato Group€26.21-0.8%€24.28€17.12▼€28.00€7.94B0.55350,354 shs382,700 shsWRBYWarby Parker$26.37-1.4%$25.00$13.63▼$29.73$2.81B2.11.33 million shs1.41 million shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGKOSGlaukos-2.44%-12.10%-10.23%-19.30%-36.08%IRTCiRhythm Technologies-2.04%-5.83%+9.70%+21.53%+129.94%STVNStevanato Group-0.83%+2.66%+16.23%+8.89%+36.01%WRBYWarby Parker-1.42%-1.38%-3.18%+20.70%+80.03%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGKOSGlaukos$80.72-2.5%$93.06$77.10▼$163.71$4.75B0.77635,607 shs1.21 million shsIRTCiRhythm Technologies$176.16-2.0%$157.12$55.92▼$187.57$5.78B1.1376,581 shs393,344 shsSTVNStevanato Group€26.21-0.8%€24.28€17.12▼€28.00€7.94B0.55350,354 shs382,700 shsWRBYWarby Parker$26.37-1.4%$25.00$13.63▼$29.73$2.81B2.11.33 million shs1.41 million shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGKOSGlaukos-2.44%-12.10%-10.23%-19.30%-36.08%IRTCiRhythm Technologies-2.04%-5.83%+9.70%+21.53%+129.94%STVNStevanato Group-0.83%+2.66%+16.23%+8.89%+36.01%WRBYWarby Parker-1.42%-1.38%-3.18%+20.70%+80.03%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGKOSGlaukos 2.79Moderate Buy$124.8354.65% UpsideIRTCiRhythm Technologies 3.00Buy$163.82-7.01% DownsideSTVNStevanato Group 2.83Moderate BuyN/AN/AWRBYWarby Parker 2.55Moderate Buy$24.06-8.76% DownsideCurrent Analyst Ratings BreakdownLatest WRBY, STVN, IRTC, and GKOS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/10/2025GKOSGlaukosBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$118.009/4/2025WRBYWarby ParkerZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold8/28/2025IRTCiRhythm TechnologiesNeedham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$180.00 ➝ $193.008/21/2025IRTCiRhythm TechnologiesCitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$167.00 ➝ $183.008/20/2025IRTCiRhythm TechnologiesBank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$200.008/15/2025GKOSGlaukosZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold8/8/2025WRBYWarby ParkerCowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy8/8/2025WRBYWarby ParkerUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral$20.00 ➝ $23.008/8/2025WRBYWarby ParkerStifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$21.00 ➝ $22.008/7/2025WRBYWarby ParkerEvercore ISISubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingPositive8/7/2025WRBYWarby ParkerTelsey Advisory GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$28.00(Data available from 9/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGKOSGlaukos$383.48M12.07N/AN/A$13.91 per share5.80IRTCiRhythm Technologies$657.23M8.61N/AN/A$2.90 per share60.74STVNStevanato Group€1.19B6.64€0.75 per share35.00€5.02 per share5.22WRBYWarby Parker$771.32M3.60$0.33 per share78.79$3.35 per share7.87Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGKOSGlaukos-$146.37M-$1.65N/AN/AN/A-21.43%-8.59%-6.61%11/3/2025 (Estimated)IRTCiRhythm Technologies-$113.29M-$2.93N/AN/AN/A-14.06%-90.03%-8.52%10/29/2025 (Estimated)STVNStevanato Group€127.45M€0.5448.5445.192.4911.73%10.34%6.21%N/AWRBYWarby Parker-$20.39M-$0.07N/A263.74N/A-1.12%-0.79%-0.41%11/6/2025 (Estimated)Latest WRBY, STVN, IRTC, and GKOS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/31/2025Q2 2025IRTCiRhythm Technologies-$0.53-$0.32+$0.21-$0.44$173.94 million$186.69 million7/30/2025Q2 2025GKOSGlaukos-$0.26-$0.24+$0.02-$0.34$115.49 million$124.12 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGKOSGlaukosN/AN/AN/AN/AN/AIRTCiRhythm TechnologiesN/AN/AN/AN/AN/ASTVNStevanato GroupN/AN/AN/AN/A1 YearsWRBYWarby ParkerN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGKOSGlaukos0.095.514.69IRTCiRhythm Technologies6.255.024.88STVNStevanato Group0.251.791.22WRBYWarby ParkerN/A2.552.23Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGKOSGlaukos99.04%IRTCiRhythm TechnologiesN/ASTVNStevanato GroupN/AWRBYWarby Parker93.24%Insider OwnershipCompanyInsider OwnershipGKOSGlaukos6.40%IRTCiRhythm Technologies1.10%STVNStevanato GroupN/AWRBYWarby Parker18.24%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGKOSGlaukos78057.35 million53.68 millionOptionableIRTCiRhythm Technologies2,00032.13 million31.91 millionOptionableSTVNStevanato Group5,521302.84 millionN/AOptionableWRBYWarby Parker3,780105.19 million86.00 millionOptionableWRBY, STVN, IRTC, and GKOS HeadlinesRecent News About These CompaniesInsider Selling: Warby Parker (NYSE:WRBY) CEO Sells 41,084 Shares of Stock1 hour ago | insidertrades.comWarby Parker (NYSE:WRBY) Rating Increased to Buy at Wall Street Zen4 hours ago | americanbankingnews.comWarby Parker (NYSE:WRBY) Raised to Buy at Wall Street Zen4 hours ago | marketbeat.comInsider Selling: Warby Parker (NYSE:WRBY) Director Sells 35,000 Shares of StockSeptember 12, 2025 | marketbeat.comDynamic Technology Lab Private Ltd Takes Position in Warby Parker Inc. $WRBYSeptember 12, 2025 | marketbeat.comWarby Parker (WRBY) Rose Following the Partnership Announcement with GoogleSeptember 11, 2025 | insidermonkey.comJoel Cutler Sells 35,000 Shares of Warby Parker (NYSE:WRBY) StockSeptember 11, 2025 | insidertrades.comEvercore ISI Reaffirms Their Hold Rating on Warby Parker (WRBY)September 9, 2025 | theglobeandmail.comWarby Parker (NYSE:WRBY) Stock Rating Lowered by Wall Street ZenSeptember 9, 2025 | marketbeat.comPetrus Trust Company LTA Makes New $706,000 Investment in Warby Parker Inc. $WRBYSeptember 8, 2025 | marketbeat.comZacks Research Upgrades Warby Parker (NYSE:WRBY) to "Hold"September 8, 2025 | marketbeat.comWarby Parker (NYSE:WRBY) Upgraded at Zacks ResearchSeptember 7, 2025 | americanbankingnews.comBosun Asset Management LLC Sells 48,130 Shares of Warby Parker Inc. $WRBYSeptember 6, 2025 | marketbeat.comNomura Holdings Inc. Purchases New Stake in Warby Parker Inc. $WRBYSeptember 6, 2025 | marketbeat.comIeq Capital LLC Buys 15,749 Shares of Warby Parker Inc. $WRBYSeptember 6, 2025 | marketbeat.comNorthern Trust Corp Decreases Stock Position in Warby Parker Inc. $WRBYSeptember 6, 2025 | marketbeat.comRaymond James Financial Inc. Lowers Position in Warby Parker Inc. $WRBYSeptember 6, 2025 | marketbeat.com12 West Capital Management LP Invests $21.42 Million in Warby Parker Inc. $WRBYSeptember 5, 2025 | marketbeat.comWarby Parker Inc. (WRBY) Presents At Goldman Sachs 32nd Annual Global Retailing Conference 2025 TranscriptSeptember 4, 2025 | seekingalpha.comUNC Management Company Inc. Buys Shares of 12,798 Warby Parker Inc. $WRBYSeptember 4, 2025 | marketbeat.comPDT Partners LLC Purchases 110,789 Shares of Warby Parker Inc. $WRBYSeptember 4, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeWRBY, STVN, IRTC, and GKOS Company DescriptionsGlaukos NYSE:GKOS$80.72 -2.04 (-2.46%) Closing price 09/15/2025 03:59 PM EasternExtended Trading$85.64 +4.92 (+6.10%) As of 05:09 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.iRhythm Technologies NASDAQ:IRTC$176.16 -3.66 (-2.04%) Closing price 09/15/2025 04:00 PM EasternExtended Trading$176.00 -0.16 (-0.09%) As of 05:08 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.Stevanato Group NYSE:STVN€26.21 -0.21 (-0.79%) As of 09/15/2025 03:59 PM EasternStevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.Warby Parker NYSE:WRBY$26.37 -0.38 (-1.41%) Closing price 09/15/2025 03:59 PM EasternExtended Trading$26.50 +0.13 (+0.50%) As of 04:47 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Warby Parker Inc. provides eyewear products in the United States and Canada. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir’s Commercial Growth Story Is Just Getting Started The Applied Digital Breakout Is Only the Beginning $100 Million Buyback in Upwork Stock Follows a Strong Quarter Reddit Hits Record Highs: Why Wall Street Is Taking Notice Royal Caribbean's 33% Dividend Hike Signals Deeper Growth FuelCell Energy's Stock: Is a Fundamental Breakout Underway? After a Strong Wall Street Debut, Klarna's Real Work Begins MarketBeat Week in Review – 09/08 - 09/12 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
